Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
approved entities : Orange save search
Terran Biosciences Granted US Patent for the World’s First New Forms of MDMA, Potentially Clearing the Path to a Future 505(b)(2) Approval
Published: 2024-04-17 (Crawled : 14:00) - biospace.com/
FNCTF | News | $11.0354 320
|
Communications
| Email alert
Add to watchlist
first patent granted approval for
Special Meeting of Churchill Capital Corp VII Stockholders to Approve Business Combination with CorpAcq and Warrant Holder Meeting to Approve Warrant Amendment Scheduled for May 21, 2024
Published: 2024-03-22 (Crawled : 12:30) - prnewswire.com
UBS J | $28.185 0.23% 300K
|
Finance
|
| O: 0.0%
H: 0.13%
C: -0.03%
business meeting
The Biden-Harris Administration Announces New Guidance to Enable Expanded Access to All FDA-Approved Contraceptives Without Cost
Published: 2024-01-23 (Crawled : 14:30) - globenewswire.com
AGRX | $0.37 15K
|
Health Technology
|
| O: 0.0%
H: 5.41%
C: -2.03%
contraceptives
FDA Approves Expanded Use of CRESEMBA® (isavuconazonium sulfate) in Children with Invasive Aspergillosis and Invasive Mucormycosis
Published: 2023-12-08 (Crawled : 22:00) - biospace.com/
FNCTF | News | $11.0354 320
|
Communications
|
| O: 0.68%
H: 0.0%
C: 0.0%
ALPMF | $9.17 16K
|
Health Technology
|
| O: -2.79%
H: 0.62%
C: 0.62%
ALPMY | $9.47 520K
|
Manufacturing
|
| O: -2.2%
H: 0.0%
C: -0.27%
cresemba fda children
Vanda Pharmaceuticals Acquires U.S. and Canadian Rights to PONVORY® (ponesimod), a Selective S1P1R Modulator Approved for Patients with Relapsing Multiple Sclerosis
Published: 2023-12-07 (Crawled : 12:00) - prnewswire.com
JNJ | News | $146.315 0.4% 1.3M
|
Health Technology
|
| O: -1.61%
H: 0.0%
C: 0.0%
VNDA | $5.095 2.51% 300K
|
Health Technology
|
| O: 6.68%
H: 1.39%
C: -7.89%
ponvory approved sclerosis pharmaceuticals
SpringWorks Therapeutics Announces FDA Approval of OGSIVEO™ (nirogacestat) as the First and Only Treatment for Adults with Desmoid Tumors
Published: 2023-11-27 (Crawled : 23:00) - globenewswire.com
FNCTF | News | $11.0354 320
|
Communications
|
| O: -2.99%
H: 0.0%
C: 0.0%
SWTX | News | $42.45 -0.05% 59K
|
Health Technology
|
| O: 10.74%
H: 16.83%
C: 7.17%
fda approval tumors treatment therapeutics
Evofem Announces Padagis Will Not Seek FDA Approval to Market a Generic Version of Phexxi® Until Evofem's Phexxi Patents Expire
Published: 2023-09-27 (Crawled : 14:30) - biospace.com/
FNCTF | News | $11.0354 320
|
Communications
|
| O: -2.28%
H: 0.0%
C: 0.0%
phexxi fda approval market
RedHill Announces FDA sNDA Approval for Talicia®
Published: 2023-09-18 (Crawled : 12:00) - biospace.com/
FNCTF | News | $11.0354 320
|
Communications
|
| O: 2.39%
H: 0.0%
C: 0.0%
RDHL | $0.425 1.0% 120K
|
Health Technology
|
| O: 14.12%
H: 5.15%
C: -16.39%
talicia fda approval
LYNPARZA® (olaparib) Plus Abiraterone and Prednisone or Prednisolone Approved in Japan for the Treatment of BRCA-Mutated Metastatic Castration-Resistant Prostate Cancer
Published: 2023-08-24 (Crawled : 12:00) - biospace.com/
FNCTF | News | $11.0354 320
|
Communications
|
| O: 1.28%
H: 0.0%
C: 0.0%
MRK | $125.12 -0.09% 1.6M
|
Health Technology
|
| O: -0.31%
H: 0.96%
C: -1.35%
lynparza japan approved cancer treatment plus
Health Alliance Plan and CareSource Secure Regulatory Approval for Medicaid Joint Venture in Michigan
Published: 2023-08-17 (Crawled : 21:00) - biospace.com/
FNCTF | News | $11.0354 320
|
Communications
| Email alert
Add to watchlist
health approval
Liquidia Submits Amendment to Add PH-ILD Indication to Tentatively Approved NDA for YUTREPIA™ (treprostinil) Inhalation Powder
Published: 2023-07-27 (Crawled : 10:00) - globenewswire.com
FNCTF | News | $11.0354 320
|
Communications
|
| O: 1.23%
H: 0.0%
C: 0.0%
UTHR | $237.49 0.24% 14K
|
Health Technology
|
| O: 0.36%
H: 0.0%
C: -0.39%
LQDA M | $13.82 0.07% 69K
|
Health Technology
|
| O: 1.35%
H: 2.87%
C: 2.24%
approved
FG Acquisition approves SPAC merger with ThinkMarkets – FinanceFeeds
Published: 2023-06-30 (Crawled : 04:20) - spacfeed.com
FNCTF | News | $11.0354 320
|
Communications
| Email alert
Add to watchlist
USCT | $11.23 13
|
n/a
| Email alert
Add to watchlist
spac acquisition
FG Acquisition Shareholders Approve ThinkMarkets Deal
Published: 2023-06-30 (Crawled : 18:00) - spacfeed.com
USCT | $11.23 13
|
n/a
| Email alert
Add to watchlist
FNCTF | News | $11.0354 320
|
Communications
| Email alert
Add to watchlist
acquisition deal
CMP Pharma, Inc Announces that Atorvaliq®, the First and Only FDA-approved Liquid Suspension of Atorvastatin is Now Available
Published: 2023-06-23 (Crawled : 13:00) - biospace.com/
FNCTF | News | $11.0354 320
|
Communications
| Email alert
Add to watchlist
atorvaliq
LYNPARZA® (olaparib) plus abiraterone approved in the US for the treatment of BRCA-mutated metastatic castration-resistant prostate cancer
Published: 2023-06-01 (Crawled : 13:20) - biospace.com/
FNCTF | News | $11.0354 320
|
Communications
| Email alert
Add to watchlist
lynparza approved cancer treatment plus
FDA Approves LYNPARZA® (olaparib) Plus Abiraterone and Prednisone or Prednisolone for Treatment of Adult Patients With BRCA-Mutated Metastatic Castration-Resistant Prostate Cancer (mCRPC)
Published: 2023-06-01 (Crawled : 12:20) - biospace.com/
MRK | $125.12 -0.09% 1.6M
|
Health Technology
|
| O: 0.23%
H: 0.84%
C: 0.24%
lynparza fda cancer treatment plus
BlackSwan Vascular Wins FDA Premarket Approval of Innovative New Treatment for Peripheral Arterial Hemorrhages
Published: 2023-04-18 (Crawled : 18:00) - prnewswire.com
FNCTF | News | $11.0354 320
|
Communications
| Email alert
Add to watchlist
fda approval treatment
Gamida Cell’s Allogeneic Cell Therapy Omisirge® (omidubicel-onlv) Receives FDA Approval
Published: 2023-04-17 (Crawled : 22:00) - biospace.com/
MC | $51.98 1.98% 34K
|
Finance
|
| O: -0.1%
H: 2.0%
C: 0.07%
omisirge fda approval cell therapy
Black Mountain Shareholders Approve 2-Month Extension with Option for More
Published: 2023-04-17 (Crawled : 21:00) - spacfeed.com
MSSA | $11.15 2
|
n/a
| Email alert
Add to watchlist
FNCTF | News | $11.0354 320
|
Communications
| Email alert
Add to watchlist
extension
Avadel Pharmaceuticals Announces FDA Authorization to Import Tentatively-Approved LUMRYZ™ Ahead of Anticipated Final Approval Decision
Published: 2023-03-22 (Crawled : 11:00) - globenewswire.com
FNCTF | News | $11.0354 320
|
Communications
|
| O: 0.0%
H: 0.0%
C: 0.0%
AVDL | $17.31 -0.4% 49K
|
Health Technology
|
| O: 7.47%
H: 8.23%
C: 0.35%
fda approval authorization pharmaceuticals
Gainers vs Losers
| 82% | 18% |
Top 10 Gainers
AGBA | News | $1.37 242.5% 76M
|
Finance
EGOX | $0.0606 68.33% 250M
|
CHRO | $1.73 41.22% 46K
|
n/a
ZCMD | $1.98 36.55% 27M
|
Commercial Services
RWOD | $10.61 32.68% 5.1M
|
n/a
NVFY | $2.77 31.28% 2.2M
|
Consumer Durables
AULT | $0.304 25.57% 47M
|
Manufacturing
WISA 4 | $7.19 22.07% 18M
|
Electronic Technology
MCB 4 | $39.53 19.43% 88K
|
Finance
PRTG | $0.285 18.75% 170K
|
Mining, Quarrying, and Oil and ...
Your saved searches
Save your searches and get alerts when important news are released.